MindBio Therapeutics Corp.
MBIO
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 770.60K | 1.03M | 62.70K | 76.80K | 29.10K |
| Depreciation & Amortization | 200.00 | -56.80K | -- | 57.80K | -- |
| Other Operating Expenses | 17.10K | -- | -- | -- | 17.80K |
| Total Operating Expenses | 787.90K | 975.70K | 62.70K | 134.60K | 46.90K |
| Operating Income | -787.90K | -975.70K | -62.70K | -134.60K | -46.90K |
| Income Before Tax | -790.00K | -919.30K | -591.70K | -250.00K | -30.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -790.00K | -919.30K | -591.70K | -250.00K | -30.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -300.00 | -3.30K | 800.00 | 2.80K | -400.00 |
| Net Income | -790.30K | -922.50K | -590.80K | -247.20K | -30.70K |
| EBIT | -787.90K | -975.70K | -62.70K | -134.60K | -46.90K |
| EBITDA | -787.70K | -975.70K | -62.70K | -105.70K | -- |
| EPS Basic | 0.00 | -0.88 | -1.76 | -0.73 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.74 | -0.18 | -0.45 | 0.00 |
| EPS Diluted | 0.00 | -0.88 | -1.76 | -0.73 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.74 | -0.18 | -0.45 | 0.00 |
| Average Basic Shares Outstanding | 343.35M | 1.04M | 336.40K | 337.90K | 110.14M |
| Average Diluted Shares Outstanding | 343.35M | 1.04M | 336.40K | 337.90K | 110.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |